Latest filing published 20 May 2026 for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Tian Wenzhi: trading record in brief
Filings by Tian Wenzhi span 2 companies, the busiest being ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares. In total, 2 filings cover trades dated from 13 May 2026 to 19 May 2026.
No open-market sale appears; the market trades are 1 purchase worth €21k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 20 May 2026, reports a transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares. The clock since the last published purchase (14 May 2026) now reads 178 days. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tian Wenzhi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 sharesShareXHKGHKEX:DA20260519E00412
- 50,000 shares@ HK$3.870.011% mcap100.0% of flowShareXHKGHKEX:DA20260513E00577Canonical exit: 11 Aug 2026 (T+90)
2 of 2 declarations